BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 38812817)

  • 1. Synergistic effect of lipoprotein(a) and high-sensitivity C-reactive protein on the risk of all-cause and cardiovascular death in patients with acute myocardial infarction: a large prospective cohort study.
    Wang Z; Tang J; Shi Q; Fang L; Liu N; Zhang J
    Front Endocrinol (Lausanne); 2024; 15():1392859. PubMed ID: 38812817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipoprotein(a), C-Reactive Protein, and Cardiovascular Risk in Primary and Secondary Prevention Populations.
    Small AM; Pournamdari A; Melloni GEM; Scirica BM; Bhatt DL; Raz I; Braunwald E; Giugliano RP; Sabatine MS; Peloso GM; Marston NA; Natarajan P
    JAMA Cardiol; 2024 Apr; 9(4):385-391. PubMed ID: 38353970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipoprotein(a) and High Sensitivity C-Reactive Protein among Patients with HIV in Ghana: The Study on Cardiovascular Risk Profile of HIV-Infected Patients on HAART (SCRIPT).
    Appiah LT; Sarfo FS; Nguah SB; Huffman MD; Stiles JK; Feinstein MJ
    Glob Heart; 2020 Nov; 15(1):74. PubMed ID: 33299770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Associations between postprocedural D-dimer, hs-CRP, LDL-C levels and prognosis of acute myocardial infarction patients treated by percutaneous coronary intervention].
    Chen RZ; Liu C; Zhou P; Tan Y; Sheng ZX; Li JN; Zhou JY; Wu Y; Yang YM; Song L; Zhao HJ; Yan HB
    Zhonghua Xin Xue Guan Bing Za Zhi; 2020 May; 48(5):359-366. PubMed ID: 32450651
    [No Abstract]   [Full Text] [Related]  

  • 5. High-sensitivity C reactive protein as a predictor of inhospital mortality in patients with cardiovascular disease at an emergency department: a retrospective cohort study.
    Yoshinaga R; Doi Y; Ayukawa K; Ishikawa S
    BMJ Open; 2017 Oct; 7(10):e015112. PubMed ID: 28988163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of lipoprotein (a) and 1 year prognosis in patients with heart failure with reduced ejection fraction.
    Li Z; Liu J; Shen J; Chen Y; He L; Li M; Xie X
    ESC Heart Fail; 2022 Aug; 9(4):2399-2406. PubMed ID: 35419980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between the serum lipoprotein-associated phospholipase A
    Dong L; Tong J; Fan S
    Cardiovasc J Afr; 2023 Nov-Dec 23; 34(5):273-277. PubMed ID: 36637451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-sensitivity C-reactive protein and low-density lipoprotein cholesterol association with incident of cardiovascular events: Isfahan cohort study.
    Nafari A; Mohammadifard N; Haghighatdoost F; Nasirian S; Najafian J; Sadeghi M; Roohafza H; Sarrafzadegan N
    BMC Cardiovasc Disord; 2022 May; 22(1):241. PubMed ID: 35614388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time-dependent prognostic effect of high sensitivity C-reactive protein with statin therapy in acute myocardial infarction.
    Kang DO; Park Y; Seo JH; Jeong MH; Chae SC; Ahn TH; Jang WY; Kim W; Park EJ; Choi BG; Na JO; Choi CU; Kim EJ; Rha SW; Park CG; Seo HS;
    J Cardiol; 2019 Jul; 74(1):74-83. PubMed ID: 30745001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and predictors of elevated high-sensitivity C-reactive protein in post-myocardial infarction patients: Insights from the VIRGO and TRIUMPH registries.
    Qintar M; Sharma PP; Pokharel Y; Tang Y; Lu Y; Jones P; Dreyer RP; Spertus JA
    Clin Cardiol; 2017 Dec; 40(12):1205-1211. PubMed ID: 29247528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cumulative Exposure to High-Sensitivity C-Reactive Protein Predicts the Risk of Cardiovascular Disease.
    Wang A; Liu J; Li C; Gao J; Li X; Chen S; Wu S; Ding H; Fan H; Hou S
    J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 29066453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. hsCRP Level and the Risk of Death or Recurrent Cardiovascular Events in Patients With Myocardial Infarction: a Healthcare-Based Study.
    Carrero JJ; Andersson Franko M; Obergfell A; Gabrielsen A; Jernberg T
    J Am Heart Assoc; 2019 Jun; 8(11):e012638. PubMed ID: 31140334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic impact of admission high-sensitivity C-reactive protein in acute myocardial infarction patients with and without diabetes mellitus.
    Lucci C; Cosentino N; Genovese S; Campodonico J; Milazzo V; De Metrio M; Rondinelli M; Riggio D; Biondi ML; Rubino M; Celentano K; Bonomi A; Capra N; Veglia F; Agostoni P; Bartorelli AL; Marenzi G
    Cardiovasc Diabetol; 2020 Oct; 19(1):183. PubMed ID: 33081810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relative Prognostic Value of Cardiac Troponin I and C-Reactive Protein in the General Population (from the Nord-Trøndelag Health [HUNT] Study).
    Sigurdardottir FD; Lyngbakken MN; Holmen OL; Dalen H; Hveem K; Røsjø H; Omland T
    Am J Cardiol; 2018 Apr; 121(8):949-955. PubMed ID: 29496193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Lipoprotein (a) Levels on Long-term Cardiovascular Outcomes in Patients with Myocardial Infarction with Nonobstructive Coronary Arteries.
    Gao S; Ma W; Huang S; Lin X; Yu M
    Am J Cardiol; 2021 Aug; 152():34-42. PubMed ID: 34130824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between temporal changes in C-reactive protein levels and prognosis in patients with previous myocardial infarction - A report from the CHART-2 Study.
    Oikawa T; Sakata Y; Nochioka K; Miura M; Abe R; Kasahara S; Sato M; Aoyanagi H; Saga C; Ikeno Y; Shiroto T; Sugimura K; Takahashi J; Miyata S; Shimokawa H;
    Int J Cardiol; 2019 Oct; 293():17-24. PubMed ID: 31358306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usefulness of high-sensitivity C-reactive protein in predicting long-term risk of death or acute myocardial infarction in patients with unstable or stable angina pectoris or acute myocardial infarction.
    Zebrack JS; Anderson JL; Maycock CA; Horne BD; Bair TL; Muhlestein JB;
    Am J Cardiol; 2002 Jan; 89(2):145-9. PubMed ID: 11792332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipoprotein (a) predicts recurrent worse outcomes in type 2 diabetes mellitus patients with prior cardiovascular events: a prospective, observational cohort study.
    Zhang Y; Jin JL; Cao YX; Zhang HW; Guo YL; Wu NQ; Zhu CG; Gao Y; Hua Q; Li YF; Xu RX; Li JJ
    Cardiovasc Diabetol; 2020 Jul; 19(1):111. PubMed ID: 32646432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biomarkers for Prediction of Cardiovascular Events in Community-Dwelling Adults Aged 40 or Older.
    Chong Y; Ren Q; Li Y; Li C; Feng F; Zhou Y
    Int Heart J; 2020 Jan; 61(1):109-114. PubMed ID: 31875617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxidized low-density lipoprotein and C-reactive protein have combined utility for better predicting prognosis after acute coronary syndrome.
    Zhang YC; Tang Y; Chen Y; Huang XH; Zhang M; Chen J; Sun YG; Li YG
    Cell Biochem Biophys; 2014 Mar; 68(2):379-85. PubMed ID: 23943054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.